Breanne Montero
Psychiatric/Mental Health · East Liverpool, OHNPI 1194153288
Payments from drug & device makers
Across 327 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$645
- AbbVie$556
- Otsuka America Pharmaceutical, Inc.$509
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$486
- Vanda Pharmaceuticals Inc.$476
- Takeda Pharmaceuticals U.S.A., Inc.$469
- plus $2K from 16 others
What the payments were for
- Food & beverage$5,51098%
- Education$741%
- Other$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 35 | $645 |
| AbbVie | 41 | $556 |
| Otsuka America Pharmaceutical, Inc. | 32 | $509 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $486 |
| Vanda Pharmaceuticals Inc. | 27 | $476 |
| Takeda Pharmaceuticals U.S.A., Inc. | 28 | $469 |
| Ironshore Pharmaceuticals Inc. | 22 | $434 |
| Corium, LLC | 20 | $402 |
| Lundbeck LLC | 26 | $389 |
| Neurocrine Biosciences, Inc. | 20 | $322 |
| Axsome Therapeutics, Inc. | 10 | $185 |
| Collegium Pharmaceutical, Inc. | 8 | $158 |
| E.r. Squibb & Sons, L.L.C. | 6 | $133 |
| Teva Pharmaceuticals USA, Inc. | 8 | $130 |
| Johnson & Johnson | 4 | $69 |
| Tris Pharma Inc | 4 | $62 |
| Neos Therapeutics, LP | 3 | $59 |
| Sage Therapeutics, LLC | 2 | $40 |
| Noven Therapeutics, LLC | 2 | $30 |
| Baxter Healthcare | 1 | $21 |
| Adlon Therapeutics L.p. | 1 | $17 |
| Alkermes, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$183
How this compares
$5,606 in reported general payments places this provider in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 31 | $318,854 |
| RexultiBrexpiprazole | 65 | $94,465 |
| TrintellixVortioxetine Hydrobromide | 145 | $77,868 |
| FanaptIloperidone | 25 | $76,878 |
| VraylarCariprazine Hcl | 40 | $66,883 |
| Lurasidone Hcl | 79 | $9,499 |
| Paliperidone ErPaliperidone | 15 | $7,118 |
| Clozapine | 34 | $3,798 |
| Chlorpromazine Hcl | 14 | $3,425 |
| Aripiprazole | 108 | $2,946 |
| Atomoxetine Hcl | 21 | $2,538 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 65 | $2,244 |
| Ramelteon | 25 | $2,100 |
| Trazodone Hcl | 159 | $1,997 |
| Hydroxyzine Pamoate | 104 | $1,577 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $130 | $318,85431 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $509 | $94,46565 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $469 | $77,868145 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $476 | $76,87825 claims |
| AbbVieVraylar | $556 | $66,88340 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.
Other psychiatric/mental health in East Liverpool
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Terri PopovitzCincinnati$161K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
- Rachael McLaughlinMaple Heights$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.